The multicentre clinical study of glucocorticoid combined antiviral drugs for the treatment of immune thrombocytopenic purpura
Phase of Trial: Phase IV
Latest Information Update: 30 Jun 2016
Price : $35 *
At a glance
- Drugs Oseltamivir (Primary) ; Glucocorticoids
- Indications Idiopathic thrombocytopenic purpura
- Focus Therapeutic Use
- 26 Jun 2016 Trial phase changed from phase I to phase IV.
- 26 Jun 2016 Status changed from recruiting to completed.
- 11 Feb 2014 New trial record